Moreover, as an anti-inflammatory agent, betulinic acid has been shown to inhibit IL-1β-induced inflammation in human osteoarthritis chondrocytes, an effect that can be reversed by GW9662, a potent synthetic PPARG antagonist [50]. Here, IL1B is linked to osteoarthritis.